US › Healthcare

XBiotech Inc (XBIT)

US · Healthcare · Biotechnology

$2.24+0.22%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-5.5M
Profit YoY
+49.4%
EPS
$-0.18

Key statistics

Market cap
$68.1M
Forward P/E
0.0
P/B
0.51
Book value
$4.43
EPS (TTM)
$-1.31
52-week high
$3.61
52-week low
$2.09
50-day MA
$2.33
200-day MA
$2.41
Beta
0.85

Analyst view

with an average price target of $18.00.

Shareholding

Insiders
24.33%
Institutions
6.81%

Largest institutional holders

FundStake
BlackRock Inc0.96%
Geode Capital Management, LLC0.76%
Vanguard Capital Management, LLC0.66%
RBF LLC0.65%
Morgan Stanley - Brokerage Accounts0.54%
Millennium Management LLC0.35%
Bridgeway Capital Management, LLC0.32%
Vanguard Fiduciary Trust Co0.30%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for XBiotech Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.